Stem cells live inside all of us. They are responsible for healing injured bone, ligaments, tendons and tissues. As people age or get injured, there may not be enough of these stem cells available to effectively heal the body. Acting as the body’s own repairmen, stem cells naturally self-renew, allowing for faster healing and recovering of damaged or worn bone or tissue due to injury or disease. By introducing new stem cells where there might be a lacking, the body can begin to heal itself without the use of invasive surgery.
Regenexx® Procedures are the nation’s leading stem cell and platelet procedures for orthopedic conditions, spine pain, common injuries and degenerative joint conditions, such as osteoarthritis and avascular necrosis. These procedures utilize a patient’s own cells to help heal damaged tissues, tendons, ligaments, cartilage, spinal disc, or bone.
As a viable alternative to elective surgery, StemCell ARTS offers the most advanced regenerative therapy solutions for patients suffering from chronic pain or injury to help mitigate downtime and the painful rehabilitation associated with invasive procedures.
StemCell ARTS employs only the latest in stem cell technology with Regenexx, the leaders in cell-based medicine, maintaining what is believed to be the world’s largest human mesenchymal stem cell re-implantation database used for orthopedic purposes. Regenexx has pioneered stem cell research and technology and continues to set and exceed the standard in regenerative medicine.
One size does not fit all regenerative patients. Regenexx’s orthopedic stem cell procedure remains the worlds most advanced, thanks to a state-of-the-art lab and customized medical solutions, created for patients by skilled laboratory technicians.
If you are suffering from a joint injury or osteoarthritis, you may be a good candidate for stem cell or blood platelet treatments. Please contact us for an appointment of complete the candidacy form below to immediately receive more information and “next steps in determining your candidacy” by email.